Francisco G. Vital-Lopez

Francisco G. Vital-Lopez

Auto-generated profile, based on publicly available information

Francisco G. Vital-Lopez

Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command , Fort Detrick, MD

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in SLEEP
Verified
Journal Article
Open access
PDF file
FVFrancisco G Vital-Lopez
Francisco G Vital-Lopez
TDTracy J Doty
Tracy J Doty
IAIan Anlap
Ian Anlap
WKWilliam D S Killgore
William D S Killgore
JRJaques Reifman
Jaques Reifman
If properly consumed, caffeine can safely and effectively mitigate the effects of sleep loss on alertness. However, there are no tools to determine the amount and time to consume caffeine to maximize its effectiveness. Here, we extended the capabilities of the 2B-Alert app, a unique smartphone application that learns an individual’s trait-like response to sleep loss, to provide personalized caffeine recommendations to optimize alertness. We prospectively validated 2B-Alert’s capabilities in a 62-hour total sleep deprivation study in which 21 participants used the app to measure their alertness throughout the study via the psychomotor vigilance test (PVT). Using PVT data collected during the first 36 hours of the sleep challenge, the app learned the participant’s sleep-loss response and provided personalized caffeine recommendations so that each participant would sustain alertness at a pre-specified target level (mean response time of 270 milliseconds) during a 6-hour period starting at 44 hours of wakefulness, using the least amount of caffeine possible. Starting at 42 hours, participants consumed 0 to 800 mg of caffeine, per the app recommendation. 2B-Alert recommended no caffeine to five participants, 100–400 mg to 11 participants, and 500–800 mg to five participants. Regardless of the consumed amount, participants sustained the target alertness level ~80% of the time. 2B-Alert automatically learns an individual’s phenotype and provides personalized caffeine recommendations in real time so that individuals achieve a desired alertness level regardless of their sleep-loss susceptibility.

9 June 2021 in SLEEP
Verified
Journal Article
Closed access
PDF file
FVFrancisco G Vital-Lopez
Francisco G Vital-Lopez
TDTracy J Doty
Tracy J Doty
JRJaques Reifman
Jaques Reifman
Study Objectives: Working outside the conventional “9-to-5” shift may lead to reduced sleep and alertness impairment. Here, we developed an optimization algorithm to identify sleep and work schedules that minimize alertness impairment during work hours, while reducing impairment during non-work hours. Methods: The optimization algorithm searches among a large number of possible sleep and work schedules and estimates their effectiveness in mitigating alertness impairment using the Unified Model of Performance (UMP). To this end, the UMP, and its extensions to estimate sleep latency and sleep duration, predicts the time course of alertness of each potential schedule and their physiological feasibility. We assessed the algorithm by simulating four experimental studies, where we compared alertness levels during work periods for sleep schedules proposed by the algorithm against those used in the studies. In addition, in one of the studies we assessed the algorithm’s ability to simultaneously optimize sleep and work schedules. Results: Using the same amount of sleep as in the studies but distributing it optimally, the sleep schedules proposed by the optimization algorithm reduced alertness impairment during work periods by an average of 29%. Similarly, simultaneously optimized sleep and work schedules, for a recovery period following a chronic sleep restriction challenge, accelerated the return to baseline levels by two days when compared to the conventional 9-to-5 work schedule. Conclusions: Our work provides the first quantitative tool to optimize sleep and work schedules and extends the capabilities of existing fatigue-management tools.

8 November 2023 in SLEEP
Verified
Journal Article
Open access
PDF file
JRJaques Reifman
Jaques Reifman
NPNikolai V Priezjev
Nikolai V Priezjev
FVFrancisco G Vital-Lopez
Francisco G Vital-Lopez
Study Objectives: Wearable sleep-tracker devices are ubiquitously used to measure sleep; however, the estimated sleep parameters often differ from the gold-standard polysomnography (PSG). It is unclear to what extent we can tolerate these errors within the context of a particular clinical or operational application. Here, we sought to develop a method to quantitatively determine whether a sleep tracker yields acceptable sleep-parameter estimates for assessing alertness impairment. Methods: Using literature data, we characterized sleep-measurement errors of 18 unique sleep-tracker devices with respect to PSG. Then, using predictions based on the unified model of performance, we compared the temporal variation of alertness in terms of the psychomotor vigilance test mean response time for simulations with and without added PSG-device sleep-measurement errors, for nominal schedules of 5, 8, or 9 hours of sleep/night or an irregular sleep schedule each night for 30 consecutive days. Finally, we deemed a device error acceptable when the predicted differences were smaller than the within-subject variability of 30 milliseconds. We also established the capability to estimate the extent to which a specific sleep-tracker device meets this acceptance criterion. Results: On average, the 18 sleep-tracker devices overestimated sleep duration by 19 (standard deviation = 44) minutes. Using these errors for 30 consecutive days, we found that, regardless of sleep schedule, in nearly 80% of the time the resulting predicted alertness differences were smaller than 30 milliseconds. Conclusions: We provide a method to quantitatively determine whether a sleep-tracker device produces sleep measurements that are operationally acceptable for fatigue management.

23 October 2025 in NEJM AI
Verified
Journal Article
Closed access
AFAndrew Frock
Andrew Frock
JRJeffrey T. Robbins
Jeffrey T. Robbins
FVFrancisco G. Vital-Lopez
Francisco G. Vital-Lopez
VDValmik Desai
Valmik Desai
GDGheorghe Doros
Gheorghe Doros
JRJaques Reifman
Jaques Reifman
Hemorrhage is the leading cause of preventable death on the battlefield, yet combat medics lack clinical decision support systems to help stratify hemorrhage risk in trauma casualties. We previously trained the Automated Processing of the Physiological Registry for Assessment of Injury Severity — Hemorrhage Risk Index (APPRAISE-HRI) software to associate patterns in vital signs (heart rate and blood pressure) collected from trauma patients with three HRI levels: I (low), II (average), or III (high). To independently validate APPRAISE-HRI and obtain U.S. Food and Drug Administration (FDA) clearance, we collected trauma registry and continuous vital sign data from 5895 trauma patients (543 with hemorrhagic injuries and 5352 controls) in an emergency department or during prehospital transport to one of eight medical centers. The study outcome was hemorrhagic injury, defined by documented injuries and blood transfusion. Using the likelihood ratio to assess the ability of APPRAISE-HRI to stratify hemorrhage risk, we found that hemorrhagic patients were 6.88 times as likely as controls to be at level III, strongly suggesting the presence of hemorrhage at this level. Similarly, hemorrhagic patients were 0.18 times as likely as controls to be at level I, suggesting the absence of hemorrhage at this level. Hemorrhagic patients were almost as likely as controls to be at level II (0.70 times as likely). Subsequently, the U.S. Department of Defense obtained FDA 510(k) clearance for the artificial intelligence–enabled APPRAISE-HRI Class II device (K233249), the first software as a medical device approved for assessing hemorrhage risk in trauma patients, allowing for triage and identification of casualties who need immediate attention and evacuation. (Funded by the U.S. Army Medical Materiel Development Activity and the Combat Casualty Care Program Area Directorate (CCCPAD) of the U.S. Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD and others.)

27 January 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JRJaques Reifman
Jaques Reifman
KKKamal Kumar
Kamal Kumar
LHLuke Hartman
Luke Hartman
AFAndrew Frock
Andrew Frock
TDTracy J Doty
Tracy J Doty
FVFrancisco G Vital-Lopez
Francisco G Vital-Lopez
Background: One-third of the US population experiences sleep loss, with the potential to impair physical and cognitive performance, reduce productivity, and imperil safety during work and daily activities. Computer-based fatigue-management systems with the ability to predict the effects of sleep schedules on alertness and identify safe and effective caffeine interventions that maximize its stimulating benefits could help mitigate cognitive impairment due to limited sleep. To provide these capabilities to broad communities, we previously released 2B-Alert Web, a publicly available tool for predicting the average alertness level of a group of individuals as a function of time of day, sleep history, and caffeine consumption. Objective: In this study, we aim to enhance the capability of the 2B-Alert Web tool by providing the means for it to automatically recommend safe and effective caffeine interventions (time and dose) that lead to optimal alertness levels at user-specified times under any sleep-loss condition. Methods: We incorporated a recently developed caffeine-optimization algorithm into the predictive models of the original 2B-Alert Web tool, allowing the system to search for and identify viable caffeine interventions that result in user-specified alertness levels at desired times of the day. To assess the potential benefits of this new capability, we simulated four sleep-deprivation conditions (sustained operations, restricted sleep with morning or evening shift, and night shift with daytime sleep) and compared the alertness levels resulting from the algorithm’s recommendations with those based on the US Army caffeine-countermeasure guidelines. In addition, we enhanced the usability of the tool by adopting a drag-and-drop graphical interface for the creation of sleep and caffeine schedules. Results: For the 4 simulated conditions, the 2B-Alert Web–proposed interventions increased mean alertness by 36% to 94% and decreased peak alertness impairment by 31% to 71% while using equivalent or smaller doses of caffeine as the corresponding US Army guidelines. Conclusions: The enhanced capability of this evidence-based, publicly available tool increases the efficiency by which diverse communities of users can identify safe and effective caffeine interventions to mitigate the effects of sleep loss in the design of research studies and work and rest schedules.

15 June 2024 in SLEEP
Verified
Journal Article
Open access
PDF file
FVFrancisco G Vital-Lopez
Francisco G Vital-Lopez
TDTracy J Doty
Tracy J Doty
JRJaques Reifman
Jaques Reifman
Study Objectives: Sleep loss can cause cognitive impairments that increase the risk of mistakes and accidents. However, existing guidelines to counteract the effects of sleep loss are generic and are not designed to address individual-specific conditions, leading to suboptimal alertness levels. Here, we developed an optimization algorithm that automatically identifies sleep schedules and caffeine-dosing strategies to minimize alertness impairment due to sleep loss for desired times of the day. Methods: We combined our previous algorithms that separately optimize sleep or caffeine to simultaneously identify the best sleep schedules and caffeine doses that minimize alertness impairment at desired times. The optimization algorithm uses the predictions of the well-validated Unified Model of Performance to estimate the effectiveness and physiological feasibility of a large number of possible solutions and identify the best one. To assess the optimization algorithm, we used it to identify the best sleep schedules and caffeine-dosing strategies for four studies that exemplify common sleep-loss conditions and compared the predicted alertness-impairment reduction achieved by using the algorithm’s recommendations against that achieved by following the U.S. Army caffeine guidelines. Results: Compared to the alertness-impairment levels in the original studies, the algorithm’s recommendations reduced alertness impairment on average by 63%, an improvement of 24 percentage points over the U.S. Army caffeine guidelines. Conclusions: We provide an optimization algorithm that simultaneously identifies effective and safe sleep schedules and caffeine-dosing strategies to minimize alertness impairment at user-specified times.